Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Jun 09, 2022 2:14pm
94 Views
Post# 34744582

RE:RE:RE:RE:RE:New Studies on KBR compared to MRI

RE:RE:RE:RE:RE:New Studies on KBR compared to MRI
G1945V wrote: Pandora to your comment:

"They seem to have the 3 levels or options in doing the heart analysis. The catheterization approach, the echo + kbr approach and the 'gold standard' MRI approach. Presumably they all have their pluses and minuses depending on urgency, location, cost, availability, etc."

Cardiac catheterization is an invasive procedure of inserting a catheter into your body cavity to get information about the heart or blood vessels. In comparison, the echo-kbr and cardiac MRI are non-invasive. We know the procedure for the echo-kbr from Ventripoint VMS+. The Cardiac MRI takes pictures of the heart and blood vessels.

Ventripoint VMS+ aims to become the gold standard for heart analysis. Cheaper and faster than a Cardiac MRI.


G1945V 


Thanks, yup, know all that. Was just trying to format a simple, brief response to GrahamB who appears to favour the MRI approach. It is the gold standard but does have limitations of which I think VPT's VMS+ can capitalize. Whether it covers the deficiencies that he was pointing out such as end-systolic volume (RVESV), stroke volume (RVSV) and ejection fraction (RVEF), I have no idea -- not smart enough for that one, so do not know if that would be a specific reference to the VMS+ product output.

Conventional transthoracic echocardiography (TTE) combined with Knowledge-based reconstruction (KBR) were the procedures being compared to MRI in this particular study i.e. "The aim of this study was to investigate the accuracy of TTE-KBR compared to the gold standard cardiac magnetic resonance imaging (CMR) in determining RV dimensions in pulmonary sarcoidosis."

How any of that relates to VMS+ and it's targeted applications I have no understanding of so cannot make any kind of knowledgeable comment -- just posting written words.
<< Previous
Bullboard Posts
Next >>